/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Marlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostics products, imaging systems, and surgical products for women's health through early detection and treatment worldwide. With a market cap of $14.5 billion, Hologic operates through Diagnostics, Breast Health, GYN Surgical, and Skeletal Health segments.
Hologic has significantly underperformed the broader market over the past year. HOLX stock has plummeted 14.2% over the past 52 weeks and 11.9% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 20.5% gains over the past year and 2.9% returns in 2025.